The importance of MRD monitoring in intensive treatment for chronic lymphocytic leukemia – a case report
Journal Title: Postępy Nauk Medycznych - Year 2015, Vol 28, Issue 6
Abstract
Chronic lymphocytic leukemia is the most common leukemia diagnosed in adults. The median age of diagnosis is 65. The goal of treatment especially in younger patients should be putting them in deep remission, without a minimal residual disease (MRD). The standard currently used to monitor response to treatment does not take into account the status of MRD. The present case-study is of a patient with chronic lymphocytic leukemia diagnosed in a 38 year old. The duration of illness as well as the observation of the patient has now been 13 years. In our case, the effects of each treatment were evaluated not only on the basis of hematological parameters and physical examination but also taking into account the condition of the minimal residual disease. Eliminating pathological CLL cell clones was only after intensive chemotherapy supportive allogeneic haematopietic stem cell transplantation from a related donor.
Authors and Affiliations
Anna Koclęga, Małgorzata Krawczyk-Kuliś, Mirosław Markiewicz, Sławomira Kyrcz-Krzemień
Keywords
Related Articles
- EP ID EP55066
- DOI -
- Views 145
- Downloads 0
New perspectives on the pathogenesis and treatment of hair disorders
In recent years, along with the progress of balding has been on the rise, which is reflected both in the prevalence of the problem and in the persistently low treatment efficacy. The leading causes of diffuse hair loss a...
Współczesne poglądy na etiologię „idiopatycznych” komorowych zaburzeń rytmu serca u dzieci
Przyczyną komorowych zaburzeń rytmu mogą być u dzieci wady serca przed i po leczeniu operacyjnym, guzy serca, kardiomiopatia przerostowa lub rozstrzeniowa, arytmogenna kardiomiopatia prawej komory, proces zapalny w mięśn...
Disease relapse and infectious complications as the main cause of stem cell transplant failure
Introduction. Hematopoietic stem cell transplantation (HSCT) is an important therapeutic method in hematology, oncology and immunology.Aim. The general overview of the results of HSCT in Bydgoszcz Transplant Center with...
Jaskra a choroba Alzheimera – wspólne patomechanizmy i metody terapii
Przez całe życie osobnicze dochodzi równolegle do utraty komórek organizmu i ich regeneracji. Wraz z wiekiem zmniejszają się zdolności regeneracyjne, a przewagę zyskują procesy katabolizmu. Starzenie się jest związane ta...
Primary immunologic thrombocytopenia (ITP) – the dawning of the thrombopoetin-receptor agonists
Recent research on the pathogenesis of chronic immune thrombocytopenia (ITP) points to a role of suboptimal platelet production. The development of of thrombopoietin-mimetic agents, which can increase platelet count by i...